UniProtKB/Swiss-Prot P11532 : Variant p.Glu1219Gln
Dystrophin
Gene: DMD
Feedback ?
Variant information
Variant position:
1219
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:
US
The variants are classified into three categories: LP/P, LB/B and US.LP/P: likely pathogenic or pathogenic. LB/B: likely benign or benign. US: uncertain significance
Residue change:
From Glutamate (E) to Glutamine (Q) at position 1219 (E1219Q, p.Glu1219Gln).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:
Change from medium size and acidic (E) to medium size and polar (Q)
The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:
2
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another: Lowest score: -4 (low probability of substitution).Highest score: 11 (high probability of substitution). More information can be found on the following page
Variant description:
In a breast cancer sample; somatic mutation.
Any additional useful information about the variant.
Sequence information
Variant position:
1219
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:
3685
The length of the canonical sequence.
Location on the sequence:
EMKRAKEEAQQKEAKVKLLT
E SVNSVIAQAPPVAQEALKKE
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:
The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human EMKRAKEEAQQKEAKVKLLTE SVNSVIAQAPPVAQEALKKE
EMKRAKEEAQQKEAKVKLLTE SVNSVIAQAPPAAQEALKKE
Mouse EMKRAKEEALQKETKVKLLTE TVNSVIAHAPPSAQEALKKE
Rat EMKRAKEEALQKEAKVKLLTE TVNSVISQAPPAAQEALKKE
Pig EMKRAKEEAQQKEAKVKLLTE SVNSVIAQAPPAAQEALKKE
Chicken ELKRAKEDAMQKEVKVKLITD SVNNFIAKAPPAANEALKKE
Caenorhabditis elegans --KRWNQLELDLEENLRKAKR DQDVFIQKRLREGEEALNE-
Sequence annotation in neighborhood:
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 3685
Dystrophin
Repeat
1157 – 1263
Spectrin 8
Alternative sequence
1 – 3068
Missing. In isoform 12, isoform 13, isoform 14, isoform 15, isoform 16 and isoform 17.
Alternative sequence
1 – 2729
Missing. In isoform 11.
Alternative sequence
1 – 2460
Missing. In isoform 6, isoform 7, isoform 8, isoform 9 and isoform 10.
Alternative sequence
2 – 1357
Missing. In isoform 4 and isoform 5.
Literature citations
The consensus coding sequences of human breast and colorectal cancers.
Sjoeblom T.; Jones S.; Wood L.D.; Parsons D.W.; Lin J.; Barber T.D.; Mandelker D.; Leary R.J.; Ptak J.; Silliman N.; Szabo S.; Buckhaults P.; Farrell C.; Meeh P.; Markowitz S.D.; Willis J.; Dawson D.; Willson J.K.V.; Gazdar A.F.; Hartigan J.; Wu L.; Liu C.; Parmigiani G.; Park B.H.; Bachman K.E.; Papadopoulos N.; Vogelstein B.; Kinzler K.W.; Velculescu V.E.;
Science 314:268-274(2006)
Cited for: VARIANTS [LARGE SCALE ANALYSIS] PHE-334; GLN-1219; HIS-1470 AND VAL-2164;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.